These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 11051369
1. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model. Orlando A, D'Antoni A, Cammà C, Albanese M, Livraghi T, Torzilli G, Virdone R, Sciarrino E, Simonetti RG, Maringhini A, Pagliaro L, Cottone M. Am J Gastroenterol; 2000 Oct; 95(10):2921-7. PubMed ID: 11051369 [Abstract] [Full Text] [Related]
2. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodés J. Hepatology; 1993 Nov; 18(5):1121-6. PubMed ID: 8225217 [Abstract] [Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H. Hepatogastroenterology; 2001 Nov; 48(41):1409-15. PubMed ID: 11677976 [Abstract] [Full Text] [Related]
4. [Percutaneous ethanol injection therapy for small hepatocellular carcinoma]. Shiina S, Imamura M, Obi S, Teratani T, Kanai F, Kato N, Niwa Y, Okudaira T, Payawal DA, Tateishi R, Shiratori Y, Omata M. Gan To Kagaku Ryoho; 1996 Jun; 23(7):835-9. PubMed ID: 8678530 [Abstract] [Full Text] [Related]
6. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Andriulli A, de Sio I, Solmi L, De Carlis L, Troisi R, Grasso A, Festa V, Caturelli E, Giacomoni A, Del Vecchio Blanco C, De Hemptinne B, Burroughs A, Perri F. Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162 [Abstract] [Full Text] [Related]
7. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Peng ZW, Zhang YJ, Chen MS, Liang HH, Li JQ, Zhang YQ, Lau WY. Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095 [Abstract] [Full Text] [Related]
8. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients. Livraghi T. Ital J Gastroenterol; 1992 Feb; 24(2):72-4. PubMed ID: 1315592 [Abstract] [Full Text] [Related]
9. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection. Andriulli A, De Sio I, Brunello F, Salmi A, Solmi L, Facciorusso D, Caturelli E, Perri F. Aliment Pharmacol Ther; 2006 May 01; 23(9):1329-35. PubMed ID: 16629938 [Abstract] [Full Text] [Related]
11. Percutaneous ethanol injection therapy in the treatment of hepatocarcinoma--results obtained from a series of 88 cases. Danila M, Sporea I, Sirli R, Popescu A. J Gastrointestin Liver Dis; 2009 Sep 01; 18(3):317-22. PubMed ID: 19795026 [Abstract] [Full Text] [Related]
12. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. Livraghi T. Hepatogastroenterology; 2001 Sep 01; 48(37):20-4. PubMed ID: 11268965 [Abstract] [Full Text] [Related]
13. [Percutaneous alcohol administration for hepatocarcinoma: long-term results]. Lencioni R, Paolicchi A, Bartolozzi C. Radiol Med; 1997 Sep 01; 94(1-2):8-13. PubMed ID: 9424657 [Abstract] [Full Text] [Related]
15. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Tanikawa K, Majima Y. Hepatogastroenterology; 1993 Aug 01; 40(4):324-7. PubMed ID: 8406300 [Abstract] [Full Text] [Related]
16. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? Huo TI, Huang YH, Chiang JH, Wu JC, Lee PC, Chi CW, Lee SD. Scand J Gastroenterol; 2007 Apr 01; 42(4):485-92. PubMed ID: 17454859 [Abstract] [Full Text] [Related]
17. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Cancer; 1996 May 01; 77(9):1792-6. PubMed ID: 8646676 [Abstract] [Full Text] [Related]
18. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Hepatogastroenterology; 2003 May 01; 50(50):480-4. PubMed ID: 12749252 [Abstract] [Full Text] [Related]
19. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy]. Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW. Rofo; 2004 Dec 01; 176(12):1794-802. PubMed ID: 15573291 [Abstract] [Full Text] [Related]
20. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Horigome H, Nomura T, Saso K, Itoh M. Am J Gastroenterol; 1999 Jul 01; 94(7):1914-7. PubMed ID: 10406259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]